39.45 -0.40 (-1.01%)
GILD
| Trade GILD now with |
Stock Details
Last Trade:39.45 Change:-0.40 (-1.01%) Prev Close:39.85 Open: 39.75 Days Range:39.24 – 39.82 52 Week Range: 39.21 - 79.37 Volume:7956146 P/E: 24.50EPS:1.61
Recent Blog Posts
Blog Posts on 01/18/13 at 12:37pm
Anything For A Buck: Jim Letourneau Looks To Canadian Biotech For Opportunity
Anything For A Buck: Jim Letourneau Looks To Canadian Biotech For Opportunity
Blog Posts on 01/11/13 at 1:49pm
Amgen Looks Like A Valuable Investment From The Biotechnology Industry
Amgen Looks Like A Valuable Investment From The Biotechnology Industry
Blog Posts on 12/28/12 at 2:42am
Canadian Biotech Isn't Dead; Following The Money To Undervalued Equities
Canadian Biotech Isn't Dead; Following The Money To Undervalued Equities
Blog Posts on 12/17/12 at 6:28am
Gilead Sciences - Shares Continue To Have Appeal, Trading At All-Time Highs
Gilead Sciences - Shares Continue To Have Appeal, Trading At All-Time Highs
Blog Posts on 12/04/12 at 7:02am
Cramer's Mad Money - A Follow-Up On 10 Anointed Growth Stocks (12/3/12)
Cramer's Mad Money - A Follow-Up On 10 Anointed Growth Stocks (12/3/12)
Blog Posts on 12/03/12 at 2:34pm
Kalydeco Approval In Canada More Important To Patients Than To Vertex
Kalydeco Approval In Canada More Important To Patients Than To Vertex
Blog Posts on 12/03/12 at 11:06am
Alexion Pharmaceuticals: On The Road From Orphan Drugs To Blockbuster Profits
Alexion Pharmaceuticals: On The Road From Orphan Drugs To Blockbuster Profits
Blog Posts on 11/30/12 at 8:47am
New Second Generation Combination Therapy For HCV - First Or Best In The Market - Part 3
New Second Generation Combination Therapy For HCV - First Or Best In The Market - Part 3
Blog Posts on 11/30/12 at 7:08am
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry